
    
      This study will be carried out in The Third Jiangyin Hospital in China and total of 120
      schizophrenia patients with one negative symptom item score of PANSSâ‰¥3 will be enrolled into
      the study. Individuals who participate in the study will be followed for 24 weeks. The
      changes in clinical symptoms and neurocognitive function will be assessed from baseline
      (week-0) to week-12, and week-24.
    
  